Elizabeth White
Geschäftsführer bei RENOVACOR, INC.
Aktive Positionen von Elizabeth White
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RENOVACOR, INC. | Geschäftsführer | - | - |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Geschäftsführer | 19.07.2021 | - |
Parent Project Muscular Dystrophy
 Parent Project Muscular Dystrophy Miscellaneous Commercial ServicesCommercial Services Parent Project Muscular Dystrophy focuses on finding a cure for Duchenne muscular dystrophy. The company was founded by Pat Furlong in 1984 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Elizabeth White
Ausbildung von Elizabeth White
| Rochester Christian University | Doctorate Degree |
| Allegheny College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Chief Operating Officer | 2 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy Miscellaneous Commercial ServicesCommercial Services Parent Project Muscular Dystrophy focuses on finding a cure for Duchenne muscular dystrophy. The company was founded by Pat Furlong in 1984 and is headquartered in Washington, DC. | Commercial Services |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Elizabeth White
- Erfahrung
